Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients. A multicenter study by EBMT IEWP.
Fekadu-Siebald J, Salzmann-Manrique E, Heusel JR, Willasch A, Hauck F, Gonzalez-Granado LI, Chavoshzadeh Z, Sharafian S, Cuntz F, Baris S, Finocchi A, Algeri M, Sherkat R, Klaudel-Dreszler M, Zeidler C, Bellanné-Chantelot C, Kindle G, Beaupain B, Paillard C, Seidel MG, Bader P, Albert MH, Neven B, Donadieu J, Bakhtiar S.
Fekadu-Siebald J, et al. Among authors: seidel mg.
Blood Adv. 2025 Jan 7:bloodadvances.2024014344. doi: 10.1182/bloodadvances.2024014344. Online ahead of print.
Blood Adv. 2025.
PMID: 39775668